European pharmaceutical stocks decline as Trump warns of additional tariffs.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 26 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Impact of U.S. Tariffs: Shares in major European pharmaceutical companies fell by 1.8% to 2% following U.S. President Donald Trump's announcement of new tariffs, including 100% duties on branded drugs.
Lack of Clarity on Tariff Application: The details regarding the application of these tariffs, particularly whether they would be in addition to existing national tariffs or exempt for countries with trade deals, remain unclear, with Japan still assessing the potential impact.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
